Summary of Company's Response

J.B. Chemicals & Pharmaceuticals Limited has provided clarification to the National Stock Exchange of India Limited regarding their financial results submission following an exchange query.

Date and Nature of Exchange Communication

  • Date of Company Response: May 21, 2026
  • Exchange Query Date: May 20, 2026 (Email dated May 20, 2026)
  • Subject of Query: Clarification on financial results submitted on May 11, 2026
  • Stock Symbol: JBCHEPHARM

Company's Clarification on Financial Results

The company clarified that:

  • The Board of Directors meeting was held on May 11, 2026
  • The meeting approved audited standalone and consolidated financial results for the financial year ended March 31, 2026
  • Mr. Sudhir Menon, Director, was present in person at the meeting and was authorized to sign the financial results
  • The results were submitted to stock exchanges under Mr. Menon's signature
  • A certified true copy of the Board resolution was provided as annexure to the response

Regulatory Compliance Reference

The response indicates compliance with SEBI Listing Obligations and Disclosure Requirements through:

  • Submission of financial results to stock exchanges
  • Proper authorization process through Board resolution
  • Certification of the resolution by Company Secretary

Authorization Details

The Board resolution passed on May 11, 2026 specifically:

  • Approved standalone and consolidated audited financial results for FY ended March 31, 2026
  • Authorized Mr. Sudhir Menon, Director, to sign the statement of audited financial results for submission to stock exchanges
  • Authorized Mr. Menon to sign extract of results for publication in newspapers on behalf of the Board

Signatory and Certification

  • Response Signatory: Sandeep Anil Phadnis, Vice President – Secretarial & Company Secretary
  • Digital Signature Timestamp: May 21, 2026 at 12:25:57 IST and 12:26:33 IST
  • Meeting Location: Board Room (Aquamarine), Cenergy IT Park, Unit A, 8th Floor, Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400 025
  • Meeting Mode: Physical attendance with video conference/audio visual means option

Topic Tags: Regulatory Response, Financial Results Submission, Compliance, Board Authorization, SEBI Listing Requirements